Susan G. Komen Inflammatory Breast Cancer Research Grant 2026–2027

Susan G. Komen Inflammatory Breast Cancer Research Grant 2026–2027

Due Date: 11/30/2026

The Susan G. Komen Inflammatory Breast Cancer Research Grant 2026–2027 offers up to US$125,000 for one year to study the biology of inflammatory breast cancer (IBC). The call supports projects that ask how IBC develops, what drives it to spread, and how those biological insights could improve detection or monitoring.

Komen is particularly interested in studies that test a clear hypothesis and use preliminary data or other compelling evidence to support a new line of investigation that could lead to a larger study. komen.org

Eligibility Criteria

  • Applicants must be independent investigators based at a U.S. nonprofit institution or organization.
  • Investigators moving into an independent role may qualify with a formal offer letter confirming a start date no later than January 18, 2027.
  • The institution must have opted in by October 9, 2026.
  • Each participating institution may nominate one applicant through its sponsored programs office or equivalent. Self-nominations are ineligible.
  • By January 18, 2027, applicants cannot be the principal investigator on an active Komen grant with IBC-specific aims or on two or more active Komen grants.
  • The project’s primary focus must be inflammatory breast cancer. komen.org

Funding Details

  • Maximum award: US$125,000.
  • Duration: One year.
  • The award cap includes both direct and indirect costs. komen.org

Deadline

  • Letter of intent: November 30, 2026, at 1:00 p.m. EST.
  • Full application invitations: By December 8, 2026.
  • Full application, by invitation only: January 18, 2027. komen.org

Further Information